CHARLOTTE, N.C.--(BUSINESS WIRE)--
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, has significantly enhanced its Premier Applied Sciences® research division with new experts, partnerships, data and capabilities.
Premier Applied Sciences partners with industry leaders to develop, teach, test and research care delivery practices and real-world interventions for healthcare improvement. With recent enhancements to its Premier Applied Sciences offering, Premier experts can now leverage new data and analytics capabilities to conduct research that tracks the total patient journey; identifies patients with pre-existing conditions or diagnoses outside of the acute-care setting; and traces pre- and post-hospital patient encounters, such as medication fills, adherence and primary care visits.
Specifically, the enhancements include:
“Our approach to healthcare research, innovation and improvement is to leverage the smartest intelligence available,” said Denise Juliano, the newly-appointed Group Vice President of Life Sciences, who now leads the Premier Applied Sciences team. “Not only is a robust clinical database imperative, but by integrating additional hospital data, microbiologic specificity and a separate linkage with claims data, Premier has created one of the most unique, intellectual and precise data assets available for healthcare research in the U.S. These enhancements will support our continued efforts to improve the cost and quality of healthcare, in partnership with life sciences companies, academic institutions and professional societies across the country.”
Premier’s research team includes epidemiologists, health economists, health services researchers, clinicians, statisticians and other experts. These experts leverage the Premier Healthcare Database to conduct data, inquiry and interventional research across all therapeutic areas, including cardiology, oncology, autoimmune diseases, infectious diseases, pain, pulmonology, gastroenterology and urology. For example, Premier works in partnership with life sciences companies to understand which therapies work best in real time and develops data-driven solutions to support them.
Examples of Premier’s current work with life sciences companies include:
“I am impressed each day by the work of the Premier Applied Sciences team and the companies we are working with,” Juliano added. “We all share a common goal: to get the answers to tomorrow’s healthcare questions today. It’s about meeting the needs of our health system members as the industry continues to evolve and shift toward value-based care and payment. Premier’s access to real-world data and analytics, leading industry innovators, a proven improvement methodology and seasoned experts allow us to get deep clinical insights on what needs to be done to make healthcare better in the future.”
With nearly two decades of research, Premier researchers have authored more than 95 articles in peer-reviewed publications. Additionally, the Premier Healthcare Database, which provides objective evidence- and population-based analyses of drugs, devices, treatments, disease states, resource utilization, epidemiology, healthcare costs and clinical outcomes, has been featured in more than 440 peer-reviewed publications.
Matters discussed in this release that are not statements of historical or current facts, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Premier to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in the conditional or future tenses or that include terms such as “believes,” “belief,” “expects,” “estimates,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. Forward-looking statements may include comments as to Premier’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside Premier’s control. More information on potential factors that could affect Premier’s financial results is included from time to time in the “Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Premier’s periodic and current filings with the SEC and available on Premier’s website at investors.premierinc.com. Forward-looking statements speak only as of the date they are made. Premier undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date.
About Premier Inc.
Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,000 U.S. hospitals and health systems and approximately 165,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.
Copyright Business Wire 2019